Sectors
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The small molecule drug developer, co-founded by a UCLA associate professor, has completed its series B round.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Exploiting research conducted at Kyoto Prefecture University of Medicine, Aurion Biotech is focusing on therapies that can restore vision.
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The metaverse technology developer has now pushed its overall funding past $750m since emerging out of Cambridge’s Department of Computer Science and Technology.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.
The round which pushed the ETH Zurich-linked carbon capture system developer's overall financing past the $800m mark.
The company, which largely remains in stealth mode, has set itself a mission of increasing the human lifespan by a decade.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
